Target
LGALS9 / Galectin 9
Synonyms
LGALS9 | Gal-9 | HUAT | Galectin 9 | Galectin-9 | LGALS9A | Tumor antigen HOM-HD-21 | Ecalectin
Modifications
Carrier-free
Conjugations
Unconjugated
Predicted Molecular Weight
The 343 amino acid recombinant protein with an N-terminal His tag has a predicted molecular mass of approximately 37.9 kD. The DTT-reduced and non-reduced protein migrate approximately above 60 kD by SDS-PAGE. The predicted N-terminal amino acid is His.
Expression System
HEK 293 Cells
Purification
Greater than 95% by SDS-PAGE
Usage Summary
Stock solutions should be prepared at no less than 10 µg/mL in sterile buffer (PBS, HPBS, DPBS, and EBSS) containing carrier protein such as 1% BSA or HSA.
Bio-Activity
Recombinant human Galectin-9 is able to agglutinate human red blood cells with an ED50 of 0.5 - 2.0 µg/ml.
Endotoxin
Less than 1 EU/µg (determined by LAL method).
Presentation
0.22 µm filtered protein solution in 20 mM MOPS, 1 mM EDTA, 300 mM NaCl, 2 mM DTT
Storage
Store unopened at 2°C to 8°C for up to 3 months, at -20°C for up to 6 months, or at -70°C for up to 1 year. Store diluted at 4°C for up to 1 month, or at -20°to -70°C for up to 3 months. Avoid freeze/thaw cycles. For maximum results, quick spin vial prior to opening.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This protein carries the LSBio 100% Guarantee.
LSBio Guarantee
About LGALS9 / Galectin 9